Evidence map›Paper›PMID 40389988›Full record

ArticleBMC medical genomics2025

N

Raghda A Elsabbagh, Ghada Abdelhady, Doris Urlaub, Mina Sandusky, Ola Khorshid, Mohamed Z Gad, Khaled Abou-Aisha, Carsten Watzl, Mona Rady

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BMC medical genomics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. The Role and Diagnostic Efficacy of the METTL14/GADD45B mCellular and molecular neurobiology · 2026
    Article
  2. Review
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Raghda A Elsabbagh *Biochemistry Department, Faculty of Pharmacy and Biotechnology, the German University in Cairo, Cairo, Egypt.
Ghada Abdelhady *Microbiology, Immunology and Biotechnology Department, Faculty of Pharmacy and Biotechnology, the German University in Cairo, Cairo, Egypt.
Doris UrlaubLeibniz Research Centre for Working Environment and Human Factors (IfADo), TU Dortmund, Dortmund, Germany.
Mina SanduskyLeibniz Research Centre for Working Environment and Human Factors (IfADo), TU Dortmund, Dortmund, Germany.
Ola KhorshidMedical Oncology Department, National Cancer Institute, Cairo University, Cairo, Egypt.
Mohamed Z GadBiochemistry Department, Faculty of Pharmacy and Biotechnology, the German University in Cairo, Cairo, Egypt.
Khaled Abou-AishaMicrobiology, Immunology and Biotechnology Department, Faculty of Pharmacy and Biotechnology, the German University in Cairo, Cairo, Egypt.
Carsten Watzl *Leibniz Research Centre for Working Environment and Human Factors (IfADo), TU Dortmund, Dortmund, Germany. Watzl@ifado.de.
Mona Rady *Microbiology, Immunology and Biotechnology Department, Faculty of Pharmacy and Biotechnology, the German University in Cairo, Cairo, Egypt. mona.rady@guc.edu.eg.

Funding

German Federal Ministry of Education and Research and the Egyptian Science, Technology, and Innovation Funding Authority (STDF) through the German-Egyptian Research Fund (GERF-REMARK Project) 33603
6 · The paper itself

Abstract

backgroundBreast cancer (BC) is the most commonly diagnosed cancer in women. N

methodsm

resultsTranscripts of NKG2D, an activating receptor that detects stressed non-self tumour cells, had significantly higher m

conclusionTranscripts with higher m

Indexed as

AdenosineBreast NeoplasmsGene Expression Regulation, NeoplasticKiller Cells, NaturalNK Cell Lectin-Like Receptor Subfamily KAlkB Homolog 5, RNA DemethylaseAlpha-Ketoglutarate-Dependent Dioxygenase FTOFemaleHumansMethylationRNA, MessengerSignal TransductionAdenosineALKBH5 protein, humanAlkB Homolog 5, RNA DemethylaseAlpha-Ketoglutarate-Dependent Dioxygenase FTOFTO protein, humanKLRK1 protein, humanNK Cell Lectin-Like Receptor Subfamily KN-methyladenosineRNA, MessengerALKBH5Breast CancerDependent pathwayFTOIndependent pathwayLyticm6A erasersN6 methyl adenosineNatural Killer CellsNKG2DRelated pathway

Identifiers

PMID40389988
PMCPMC12090489

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.